Quoted Micro 25 May 2026

AQUIS STOCK EXCHANGE Time to ACT (TTA) says that Ruth Herbert has been appointed chief executive of EET Hydrogen and power, which is a potential client, and final investment decision for the HPP1 blue hydrogen project is due in the second half of 2026. Time to ACT has completed the acquisition of MTE Heat Treatment […]

Quoted Micro 27 April 2026

AQUIS STOCK EXCHANGE Silverwood Brands (SLWD) has published delayed results for the 18 months to June 2025. There were delays in consolidating the Japanese subsidiary accounts and the company intends to improve its financial reporting capability. Full year revenues were £23.9m and the reported loss was £18.3m. That was predominantly down to impairment charges. Cash […]

Quoted Micro 20 April 2026

AQUIS STOCK EXCHANGE Oscillate (SRVL) is raising £2.96m at 22.5p/share ahead of joining AIM on 27 April. This values the mining company, which is changing its name to Serval Resources, at £7.6m. Equipmake (EQIP) has announced a further £950,000 order with Agrale for electric drivetrain systems for nine buses in South America. They will be […]

Quoted Micro 16 March 2026

AQUIS STOCK EXCHANGE Marula Mining (MARU) is still investigating various sources of additional finance. The directors and related parties are providing funding. An $8m copper concentrate purchase agreement has been secured with a New York company. This covers 2,500 tonnes of copper concentrate each month from the Kinusi copper mine. The 2024 accounts have still […]

Quoted Micro 9 March 2026

AQUIS STOCK EXCHANGE Mendell Helium (MDH) says M3 Helium, which it has an option to acquire that has been extended to 30 April, will commence drilling of the next Fort Dodge well during March. This is near to the Rost 1-26 well. Further drilling permits are being sought for deeper helium prospects. A US investor […]

Quoted Micro 26 January 2026

AQUIS STOCK EXCHANGE Cardiometabolic health products developer ProBiotix Health (PBX) increased sales by 45% to £2.72m in 2025 and reduced the loss. During the year, ProBiotix entered the Korean market and submitted applications for two new clinical trials. There was £1.27m in the bank at the end of £1.27m. The order book is worth £1.3m. […]

Quoted Micro 12 January 2025

AQUIS STOCK EXCHANGE AI company Astrid Intelligence (ASTR) is transitioning into execution and infrastructure-led growth. Astrid Intelligence owns and operates Subnet 127 within the Bittensor network, whose brand has been changed from SigmaArena to Astrid Arena. Bilateral arrangements have been secured with subnet operators. Astrid Vault, a protocol-native infrastructure platform intended to facilitate orderly liquidity coordination […]

Quoted Micro 24 November 2025

AQUIS STOCK EXCHANGE Kasei Digital Assets (KASH) plans a return of cash to shareholders. There should be £3.4m in cash after selling assets and this should be returned to shareholders. A subscription of £200,000 at 1p/share will provide an additional £100,000 for distribution. The new investors include new executive chairman Kwasi Kwarteng, the former Chancellor […]

Quoted Micro 15 September 2025

AQUIS STOCK EXCHANGE Newbury Racecourse (NYR) increased interim turnover 4% to £9.67m and the loss reduced to £150,000. Hospitality, hotel and nursery revenues all increased. Higher attendances improved core revenues as well. Changes in betting tax rates could hold back racing revenues. ProBiotix Health (PBX) increased interim revenues by one-third to £1.34m. This helped to […]

Quoted Micro 8 September 2025

AQUIS STOCK EXCHANGE AI technology developer Astrid Intelligence (ASTR) moved from the Main Market to the Access segment of Aquis on 3 September. The company was previously a CBD and health products retailer known as Cellular Goods and most recently it was called Cel AI. It is developing autonomous AI agents that provide personalised wellness […]